Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

Stem cells, cancer, and cancer stem cells

Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738

Identification of human brain tumour initiating cells

Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177

Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., Vitis, S. D., Fiocco, R., Foroni, C., DiMeco, F., & Vescovi, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262

A Perivascular Niche for Brain Tumor Stem Cells

Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Hypoxia in cancer: significance and impact on clinical outcome

Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D. K., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,844

Cancerous stem cells can arise from pediatric brain tumors

Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M. D., Geschwind, D. H., Bronner-Fraser, M. E., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,842

CD 133: holy of grail of neuro‐oncology or promiscuous red‐herring?

Donovan, L., & Pilkington, G. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00842.x · Cited by 13

Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression without Increasing Invasiveness

Yan, H., Romero-López, M., Frieboes, H. B., Hughes, C. C. W., & Lowengrub, J. S. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2615566 · Cited by 13

SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells

Wen, L., Wang, X.-Z., Qiu, Y., Zhou, Y., Zhang, Q., Cheng, S., Sun, J., Jiang, X., Rayner, S., Britt, W. J., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011316 · Cited by 13

The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies

Bamodu, O. A., Chung, C., Pisanic, T. R., & Wu, A. T. H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1404628 · Cited by 13

Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis

Mulkearns-Hubert, E. E., Hajdari, N., Hong, E. S., Jacobs, A. P., Gaboriau, A., Giltner, S., Tannish, G., Kay, K. E., Wang, S. Z., LaViolette, P. S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116303 · Cited by 13

In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression

Garcion, E. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1271 · Cited by 13

Cancer Stem Cells: Are they Responsible for Treatment Failure?

Maugeri‐Saccà, M., Vici, P., Lauro, L. D., Barba, M., Amoreo, C. A., Gallo, E., Mottolese, M., & Maria, R. D. (2014) · Future Oncology · doi:10.2217/fon.14.126 · Cited by 13

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

Barba, M., Vici, P., Pizzuti, L., Lauro, L. D., Sergi, D., Benedetto, A. D., Ercolani, C., Sperati, F., Terrenato, I., Botti, C., et al. (2017) · BMC Cancer · doi:10.1186/s12885-016-3045-z · Cited by 13

Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose

Walker, K. D., Boyd, N., Anderson, J. C., Willey, C. D., & Hjelmeland, A. B. (2018) · Biomarker Research · doi:10.1186/s40364-018-0136-9 · Cited by 13

How Reciprocal Interactions Between the Tumor Microenvironment and Ion Transport Proteins Drive Cancer Progression

Elingaard-Larsen, L. O., Rolver, M. G., Sørensen, E. E., & Pedersen, S. F. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_23 · Cited by 14

New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma

Hide, T., Makino, K., Nakamura, H., Yano, S., Anai, S., Takezaki, T., Kuroda, J.-I., Shinojima, N., Yutaka, U. E. D. A., & Kuratsu, J. (2013) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra2013-0207 · Cited by 13

Cancer Stem Cells

Woodward, W. A., & Hill, R. P. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-662-49651-0_2 · Cited by 13

Metastasis of Colorectal Cancer

Beauchemin, N., & Huot, J. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8 · Cited by 13

Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia

Yu, Y., Wang, Y., Wang, Y., Wang, X., Liu, Y., Wang, J., Du, C., Wang, L., Li, M., Luo, F., et al. (2016) · Scientific Reports · doi:10.1038/srep34239 · Cited by 13

Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment

Mu, Y., Zhang, Z., Zhou, H., Ma, L., & Wang, D. (2024) · Biomaterials Science · doi:10.1039/d4bm00665h · Cited by 12

Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs

Lanskikh, D., Kuziakova, O., Baklanov, I., Penkova, A. O., Doroshenko, V., Buriak, I., Zhmenia, V., & Kumeiko, V. V. (2024) · Cells · doi:10.3390/cells13242085 · Cited by 12

Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma

Takahashi, H., Inoue, A., Kawabe, Y., Hosokawa, Y., Iwata, S., Sugimoto, K., Yano, H., Yamashita, D., Harada, H., Kohno, S., et al. (2014) · Brain Tumor Pathology · doi:10.1007/s10014-014-0203-3 · Cited by 12

Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis

Tsai, Y.-T., Wu, C.-C., Ko, C., Hsu, T., Chang, W., Lo, W.-L., & Chuang, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.140 · Cited by 12

Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma

Sun, Y., Tian, Y., Wang, G., Zhao, S., Han, B. R., Li, Y., & Jiang, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030235 · Cited by 12

Demand Forecasting Of Engine Oil For Automotive And Industrial Lubricant Manufacturing Company Using Neural Network

Sharma, R., & Singhal, P. (2019) · Materials Today Proceedings · doi:10.1016/j.matpr.2019.07.013 · Cited by 12

Hypoxia increases the expression of stem cell markers in human osteosarcoma cells

Lin, J., Wang, X., Wang, X., Wang, S., Shen, R., Yang, Y., Xu, J.-Y., & Lin, J. (2021) · Oncology Letters · doi:10.3892/ol.2021.12478 · Cited by 12

Integrated Metabolomics and Transcriptomics Analysis of Monolayer and Neurospheres from Established Glioblastoma Cell Lines

Peixoto, J., Janaki‐Raman, S., Schlicker, L., Schmitz, W., Walz, S., Winkelkotte, A. M., Herold‐Mende, C. C., Soares, P., Schulze, A., & Lima, J. P. (2021) · Cancers · doi:10.3390/cancers13061327 · Cited by 12

Advances in Cancer Stem Cell Biology

Scatena, R., Giardina, B., & Mordente, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0809-3 · Cited by 13

Metabolic remodeling in astrocytes: Paving the path to brain tumor development

Jaraíz-Rodríguez, M., del Prado, L., & Balsa, E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106327 · Cited by 12

Logical design of synthetic cis-regulatory DNA for genetic tracing of cell identities and state changes

Schmitt, M. J., Dramaretska, Y., Serresi, M., Kertalli, S., Jiang, B., Yin, J., Aguzzi, A., Barozzi, I., & Gargiulo, G. (2024) · Nature Communications · doi:10.1038/s41467-024-45069-6 · Cited by 13

Lipid metabolic rewiring in glioma‑associated microglia/macrophages (Review)

Ma, Y., Huang, Y., Hu, F., & Shu, K. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5426 · Cited by 11

Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas

Sánchez‐Castillo, A., Savelkouls, K. G. M., Baldini, A., Hounjet, J., Sonveaux, P., Verstraete, P., Keersmaecker, K. D., Dewaele, B., Björkblom, B., Melin, B. S., et al. (2024) · Oncogenesis · doi:10.1038/s41389-024-00540-3 · Cited by 11

Dual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatment

Yao, Q., Lv, S., Xie, C., Du, S., & Yao, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.058 · Cited by 11

Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy

Khandekar, D., Amara, S., & Tiriveedhi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00315 · Cited by 12

Hypoxia Regulated Gene Network in Glioblastoma Has Special Algebraic Topology Structures and Revealed Communications Involving Warburg Effect and Immune Regulation

Mao, X., Xue, X., Wang, L., Wang, L., Li, L., & Zhang, X. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00704-5 · Cited by 11

A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas

Nakahara, Y., Ito, H., Namikawa, H., Furukawa, T., Yoshioka, F., Ogata, A., Masuoka, J., & Abé, T. (2022) · Brain Sciences · doi:10.3390/brainsci12040473 · Cited by 12

Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors

Tatari, N., Zhang, X., Chafe, S. C., McKenna, D., Lawson, K. A., Subapanditha, M., Shaikh, M. V., Seyfrid, M., Savage, N. J., Venugopal, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905768 · Cited by 12

The ambivalent nature of the relationship between lymphatics and cancer

Choi, J., Choi, E., & Choi, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.931335 · Cited by 11

Global research trends and hotspots on glioma stem cells

Song, S., Wu, H., Wang, F., Jiao, J., Xu, L., Wang, H., Tong, X., & Yan, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.926025 · Cited by 11

HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions

Xiong, S., Wang, D., Tang, Y., Lu, S., Huang, L., Wu, Z., Lei, S., Liang, G., Yang, D., Li, D., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147288 · Cited by 11

Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies

Higginbottom, S. L., Tomaskovic‐Crook, E., & Crook, J. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10100-7 · Cited by 12

Cancer stem cells may be mostly maintained by fluctuating hypoxia

Sun, Q., Li, X., Lu, X., & Di, B. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.11.023 · Cited by 11

Phage Display Targeting Identifies Eya1 as a Regulator of Glioblastoma Stem Cell Maintenance and Proliferation

Kim, J., She, C., Potez, M., Huang, P. C., Wu, Q., Prager, B. C., Qiu, Z., Bao, S., Rich, J. N., & Liu, J. K. (2021) · Stem Cells · doi:10.1002/stem.3355 · Cited by 11

Non-flavonoids Targeting Cancer Stem Cells: A Promising Therapeutic Avenue for Cancer Treatment

Uddin, F., & Hoque, M. (2021) · Springer eBooks · doi:10.1007/978-981-16-4935-6_8 · Cited by 11

Potential regulation of glioma through the induction of apoptosis signaling via Egl-9 family hypoxia-inducible factor 3

Mao, K., You, C., Lei, D., & Zhang, H. (2016) · Oncology Letters · doi:10.3892/ol.2016.5492 · Cited by 11

Hypoxia in Mesenchymal Stem Cell

Widowati, W., Rihibiha, D. D., Khiong, K., Widodo, M. A., Sumitro, S. B., & Bachtiar, I. (2017) · InTech eBooks · doi:10.5772/65510 · Cited by 11

Analysis of Hypoxia and the Hypoxic Response in Tumor Xenografts

Böğürcü, N., Seidel, S., Garvalov, B. K., & Acker, T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7665-2_25 · Cited by 11

Hypoxia, Gene Expression, and Metastasis

Razorenova, O. V., & Giaccia, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_3 · Cited by 11

Molecularly targeted therapy in neuro-oncology

Sathornsumetee, S., & Rich, J. N. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52138-5.00018-9 · Cited by 11

Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy

Semenza, G. L. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100075 · Cited by 10

Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers

Abdel-Maksoud, Y. T., Abdelhaseb, A. H., Abdo, A. A.-E., Kamel, A. M., Elsebay, M. T., & Attia, M. S. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i9.108731 · Cited by 10

La niche des cellules souches tumorales dans le glioblastome : des aspects fondamentaux au ciblage thérapeutique

Turpin, A., Sharif, A., Stoven, L., Blond, S., Maurage, C., & Rhun, É. L. (2015) · Bulletin du Cancer · doi:10.1016/j.bulcan.2014.07.001 · Cited by 10

Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls

Dahlrot, R. H., S⊘rensen, M. D., Rosager, A. M., Hellwege, S., Bangs⊘, J. A., Rosenberg, T., Petterson, S. A., Klitkou, J., Fosmark, D. S., Hansen, S., et al. (2014) · CNS Oncology · doi:10.2217/cns.14.30 · Cited by 10

Preferential activation of HIF-2α adaptive signalling in neuronal-like cells in response to acute hypoxia

Baudel, M. A. S. M., Rae, M. T., Darlison, M. G., Poole, A. V., & Fraser, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185664 · Cited by 10

Tumor Metabolism: A New Field for the Treatment of Glioma

Chai, X., Zhang, Y., Zhang, W., Feng, K., Jiang, Y., Zhu, A., Chen, X., Di, L., & Wang, R. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00287 · Cited by 10

Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor

Sheehan, J. P., Popp, B., Monteith, S. J., Toulmin, S. A., Tomlinson, J., Martin, J., Cifarelli, C. P., Lee, D.-H., & Park, D. M. (2011) · Journal of neurosurgery · doi:10.3171/2011.5.jns101954 · Cited by 10

Correlation of high delta-like ligand 4 expression with peritumoral brain edema and its prediction of poor prognosis in patients with primary high-grade gliomas

Qiu, X., Wang, C., Lin, Z., You, N. Y., Wang, X., Chen, Y., Chen, L., Liu, S.-Y., & Kang, D. (2015) · Journal of neurosurgery · doi:10.3171/2014.12.jns14768 · Cited by 10

Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition

Day, E. K., Zhong, Q., Purow, B. W., & Lazzara, M. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1756 · Cited by 10

Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment

Qin, X., Liu, L., Li, Y., Zhang, P., Han, D., & Dong, L. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1952595 · Cited by 10

Differential Expression of Hypoxia-Related Genes in Primary Brain Tumors and Correlation with Clinicopathologic Data

Bayat, S., Mamivand, A., Khoshnevisan, A., Maghrouni, A., Shabani, S., Raouf, M. T., Yaseri, M., Saffar, H., & Tabrizi, M. H. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.07.068 · Cited by 11

Understanding autophagy role in cancer stem cell development

Aguilar-Gallardo, C., Zamorano, M., Farías, J. G., & Quevedo, K. D. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07299-z · Cited by 10

Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions

Celada, L., Cubiella, T., San‐Juan‐Guardado, J., Martínez, A. S. J., Valdés, N., Jiménez‐Fonseca, P., Díaz, I., Enguita, J. M., Astudillo, A., Álvarez-González, E., et al. (2022) · Cancers · doi:10.3390/cancers14122986 · Cited by 11

Critical multiple angiogenic factors secreted by glioblastoma stem‐like cells underline the need for combinatorial anti‐angiogenic therapeutic strategies

Thirant, C., Gavard, J., Junier, M., & Chneiweiss, H. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200102 · Cited by 10

Cancer Stem Cells as a Target Population for Drug Discovery

Bouvard, C., Barefield, C., & Zhu, S. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.106 · Cited by 10

Hemangioblastoma Stromal Cells Show Committed Stem Cell Phenotype

Welten, C. M., Keats, E. C., Ang, L.-C., & Khan, Z. A. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015675 · Cited by 10

Over Expression of BCL2 and Low Expression of Caspase 8 Related to TRAIL Resistance in Brain Cancer Stem Cells

Qi, L., Ren, K., Fang, F., Zhao, D., Yang, N.-J., & Li, Y. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.4849 · Cited by 10

Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives

López-Gómez, M., Casado, E., Muñoz, M., Alcalá, S., Moreno‐Rubio, J., D’Errico, G., Jimenez-Gordo, A. M., Salinas, S., & Sáinz, B. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.08.006 · Cited by 10

Cancer initiating-cells are enriched in the CA9 positive fraction of primary cervix cancer xenografts

Marie-Egyptienne, D. T., Chaudary, N., Kalliomäki, T., Hedley, D. W., & Hill, R. P. (2016) · Oncotarget · doi:10.18632/oncotarget.13625 · Cited by 10

Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma

Matsumoto, T., Chino, H., Akiya, M., Hashimura, M., Yokoi, A., Tochimoto, M., Nakagawa, M., Jiang, Z., & Saegusa, M. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23265 · Cited by 10

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Sun, M. A., Yang, R. R., Liu, H., Wang, W., Song, X., Hu, B., Reynolds, N., Roso, K., Chen, L. H., Greer, P. K., et al. (2023) · Cancers · doi:10.3390/cancers15184619 · Cited by 9

Cancer stem cells: Masters of all traits

Leck, L. Y. W., El-Aziz, Y. S. A., McKelvey, K. J., Park, K. C., Sahni, S., Lane, D. J. R., Skoda, J., & Jansson, P. J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167549 · Cited by 9

Role of cancer stem cells in brain tumors

Chen, Y.-H., Hung, M., & Shyu, W. (2012) · Biomedicine · doi:10.1016/j.biomed.2012.06.001 · Cited by 9

Stem Cells: Current Status and Therapeutic Implications

Reddy, K. B. (2020) · Genes · doi:10.3390/genes11111372 · Cited by 9

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo

Niessner, H., Burkard, M., Leischner, C., Renner, O., Plöger, S., Meraz-Torres, F., Böcker, M., Hirn, C., Lauer, U. M., Venturelli, S., et al. (2022) · Cells · doi:10.3390/cells11071229 · Cited by 9

Role of yUbp8 in Mitochondria and Hypoxia Entangles the Finding of Human Ortholog Usp22 in the Glioblastoma Pseudo-Palisade Microlayer

Luca, V. D., Leo, M., Cretella, E., Montanari, A., Saliola, M., Ciaffi, G., Vecchione, A. M., Stoppacciaro, A., & Filetici, P. (2022) · Cells · doi:10.3390/cells11101682 · Cited by 9

Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension

Góźdź, A., Wojtaś, B., Szpak, P., Szadkowska, P., Czernicki, T., Marchel, A., Wójtowicz, K., Kaspera, W., Ładziński, P., Szopa, W., et al. (2022) · Cancers · doi:10.3390/cancers14194852 · Cited by 9

The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single-Cell Analysis

Yan, H., Zhu, J., Ping, Y., Yan, M., Liao, G., Yuan, H., Zhou, Y., Xiang, F., Pang, B., Xu, J., et al. (2022) · Stem Cells · doi:10.1093/stmcls/sxac088 · Cited by 10

Predominant factors influencing reactive oxygen species in cancer stem cells

Soundararajan, L., Warrier, S. R., Dharmarajan, A., & Bhaskaran, N. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30506 · Cited by 9

Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine

Qian, D., Liu, Y., Zheng, J., & Cai, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01782-7 · Cited by 9

Surgical management of high-grade glioma: a standard of care

Watts, C. (2012) · CNS Oncology · doi:10.2217/cns.12.26 · Cited by 9

Nonlinear ghost waves accelerate the progression of high-grade brain tumors

Gil, R. P. S., Martínez‐González, A., & Pérez‐García, V. M. (2016) · Communications in Nonlinear Science and Numerical Simulation · doi:10.1016/j.cnsns.2016.03.014 · Cited by 9

Heterogenic expression of stem cell markers in patient-derived glioblastoma spheroid cultures exposed to long-term hypoxia

Rosenberg, T., Aaberg-Jessen, C., Petterson, S. A., & Kristensen, B. W. (2018) · CNS Oncology · doi:10.2217/cns-2017-0034 · Cited by 9

SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling

Nie, Z., Cai, S., Wei, Z., Li, Y., Bian, L., Wang, C., Wang, X., & Wang, C. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.040 · Cited by 9

Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells

Schmidt, J., Oppermann, E., Blaheta, R. A., Schreckenbach, T., Lunger, I., Rieger, M. A., Bechstein, W. O., Holzer, K., & Malkomes, P. T. Z. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111382 · Cited by 9

Brain tumor stem cells

Palm, T., & Schwamborn, J. C. (2010) · Biological Chemistry · doi:10.1515/bc.2010.059 · Cited by 9

Pro-tumorigenic AMPK in glioblastoma

Leli, N. M., & Koumenis, C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0129-9 · Cited by 9

Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma

Karakaya, S., Gunnesson, L., Elias, E., Salvo, P. M., Robledo, M., Nilsson, O., Wängberg, B., Abel, F., Påhlman, S., Muth, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38606-8 · Cited by 8

Triiodothyronine promotes the proliferation and chemoresistance of cholangiocarcinoma cells via HIF-1α/Glut1-stimulated glycolysis

Huang, D., Xu, F., Xu, L., Tang, Z., Hu, Y., Li, J., & Yu, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167814 · Cited by 8

Is Hypoxic/Altitude Training an Important Topic in the Field of Hypoxia?

Millet, G. P., Burtscher, M., & Burtscher, J. (2021) · Journal of Science in Sport and Exercise · doi:10.1007/s42978-021-00144-y · Cited by 8

Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview

Eatmann, A. I., Hamouda, E., Hamouda, H., Farouk, H. K., Jobran, A. W. M., Omar, A. A., Madeeh, A. K., Al-dardery, N. M., Elnoamany, S., Abd-Elnasser, E. G., et al. (2023) · Metabolites · doi:10.3390/metabo13040543 · Cited by 8

Insight into the transcription factors regulating Ischemic stroke and glioma in response to shared stimuli

Waseem, A., Rashid, S., Rashid, K., Khan, M. A., Khan, R., Haque, R., Seth, P., & Raza, S. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.006 · Cited by 8

The effects of extra high dose rate irradiation on glioma stem-like cells

Jing, H., Godley, A. R., Shoemake, J. D., Han, Z., Magnelli, A., & Yu, J. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202533 · Cited by 8

EPAS1/HIF2α correlates with features of low-risk neuroblastoma and with adrenal chromaffin cell differentiation during sympathoadrenal development

Westerlund, I., Shi, Y., & Holmberg, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.076 · Cited by 8

Roxadustat regulates iron metabolism in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A meta-analysis

Hou, Y., Wang, C., Mao, X.-Y., Zhang, M.-Z., & Li, B. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.06.008 · Cited by 8

Preclinical modeling of lower-grade gliomas

Tang, L. W., Mallela, A. N., Deng, H., Richardson, T. E., Hervey‐Jumper, S. L., McBrayer, S. K., & Abdullah, K. G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1139383 · Cited by 8

HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells

Carcelén, M., Velásquez, C., Vidal, V., Gutierrez, O., & Fernández-Luna, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020741 · Cited by 8

Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models

Douglas, C. R., Jain, S., Lomeli, N., Lepe, J. J., Di, K., Nandwana, N. K., Mohammed, A. S., Vu, T., Pham, J., Kenney, M. C., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107697 · Cited by 7

Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches

Ribeiro, A., Fote, G., Himstead, A. S., Zheng, M., Elliott, E., Smith, S. M., Lou, J. J., & Yuen, C. (2025) · Biomedicines · doi:10.3390/biomedicines13081963 · Cited by 7

Targeting Glioblastoma Stem Cells: Therapeutic Strategies and Clinical Perspectives

Rachamala, H. K., Lourembam, S. D., Mukhopadhyay, D., & Angom, R. S. (2026) · Cancers · doi:10.3390/cancers18091353 · Cited by 7

Common Postzygotic Mutational Signatures in Healthy Adult Tissues Related to Embryonic Hypoxia

Hong, Y., Zhang, D., Zhou, X., Chen, A., Abliz, A., Bai, J., Wang, L., Hu, Q., Gong, K., Guan, X., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.09.005 · Cited by 8

NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas

Patel, B., Pugazenthi, S., English, C. W., Nitturi, V., Pari, S. S., Mahlokozera, T., Leidig, W. A., Lu, H., Yang, A., Roberts, K. F., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf022 · Cited by 7

Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma

Damjanovic, S. S., Ilic, B. B., Čokić, B. B., Antic, J. A., Bankovic, J. Z., Milicevic, I., Rodic, G., Ilic, D. S., Todorovic, V. N., Puškaš, N., et al. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.11.003 · Cited by 7

Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture

Sundar, S. J., Shakya, S., Recinos, V., & Hubert, C. G. (2022) · Journal of Visualized Experiments · doi:10.3791/63745 · Cited by 7

RNA Sequencing in Hypoxia-Adapted T98G Glioblastoma Cells Provides Supportive Evidence for IRE1 as a Potential Therapeutic Target

White, B. E., Liu, Y., Hakonarson, H. H., & Buono, R. J. (2023) · Genes · doi:10.3390/genes14040841 · Cited by 7

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma

Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02100-5 · Cited by 6

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813

The role of hypoxia in modulating glioma cell tumorigenic potential

Heddleston, J. M. (2011) · OhioLink ETD Center (Ohio Library and Information Network)

Differential Angiogenic Capability and Hypoxia Responses in Glioma Stem Cells

Li, Z. (2009) · DukeSpace (Duke University)

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α

Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α

Seidel, S., Garvalov, B. K., Wirta, V., von Stechow, L., Schänzer, A., Meletis, K., Wolter, M., Sommerlad, D., Henze, A., Nistér, M., et al. (2010) · Brain · doi:10.1093/brain/awq042 · Cited by 462